Mass Tort Defense: Rights and Response Options

Mass torts arise when a single product, environmental exposure, or event causes injury to numerous individuals, each of whom may pursue a separate claim but whose cases are often consolidated for pretrial management. The defining characteristic is the parallel causation question: did the defendant's conduct cause harm to each plaintiff, or does the injury stem from other sources? Courts manage these cases through multidistrict litigation (MDL) in federal court or coordinated state court proceedings, which streamline discovery and motion practice but also create pressure to settle large tranches of claims at once.

From a practitioner's perspective, the challenge is that individual defenses (comparative fault, lack of exposure, alternative causation) must be evaluated across a population rather than a single case. This means early investigation into the universe of potential claimants, their exposure histories, and the scientific or factual basis for causation becomes essential. Defendants often face discovery requests that seek production of thousands of documents and depositions of multiple corporate representatives, all while managing settlement discussions that may involve claims valuation models and bellwether trials.

Defense strategy in mass tort litigation balances individual case strength against aggregate settlement economics. A defendant facing 10,000 claims cannot litigate each one to judgment; instead, strategy focuses on identifying subgroups of claims with weaker causation evidence, negotiating global settlement frameworks, and managing trial risk through bellwether cases that test jury receptivity to defense theories.

Mass tort discovery is exponentially more burdensome than single-case discovery. Defendants typically face requests for all documents related to product design, testing, marketing, adverse event reports, and regulatory communications. The sheer volume of discovery—often millions of pages—requires robust document management systems and careful privilege review to avoid inadvertent waiver. Additionally, defendants must produce representatives for depositions covering corporate knowledge, decision-making, and risk awareness across multiple time periods and business units.

In practice, these disputes rarely map neatly onto a single rule. Courts may impose page limits on document production, require parties to use search protocols or keyword filters, or order phased discovery to manage burden. A New York federal court managing a consolidated product liability MDL, for example, may require defendants to produce core documents first, then reserve supplemental production for later phases, which can delay resolution but prevents overwhelming the parties early on. The timing of discovery disputes and how thoroughly a defendant documents its decision-making process at the outset often determine whether courts will impose sanctions or limit later discovery scope.

Understanding mass torts requires recognizing that they operate as a distinct category of complex litigation with unique procedural and economic pressures. Defendants should evaluate whether claims also implicate regulatory enforcement, criminal liability, or other parallel proceedings. For instance, environmental mass torts may involve EPA enforcement, and pharmaceutical cases may trigger FDA review or federal extortion defense considerations if settlement demands are viewed as coercive. Early assessment of the full litigation ecosystem helps defendants allocate resources and prioritize which forums present the greatest risk.

Forward-looking defense planning should focus on documenting the scientific and factual basis for contesting causation in the early stages of litigation, identifying and preserving key corporate witnesses and their knowledge, assessing whether the defendant's insurance policies provide adequate coverage for defense costs and settlements, and evaluating whether early settlement of clearly defensible claims may preserve resources for contested cases. Defendants should also prepare for the possibility that some mass tort litigation may settle through a class action framework or trust fund, which can offer finality but requires careful negotiation of release terms and claims procedures.